As VC funds shovel money into start-ups, they have noticeably stayed away from Juul, even as it exploded in growth and catapulted to become the most valuable vape brand. Erin Griffith, correspondent for the New York Times, said investors appear to be taking a moral stand, even as they simultaneously invest in other nicotine-delivery products.
For full interview [click here](https://cheddar.com/videos/silicon-valley-shuns-juul-supports-nicotine-elsewhere).
Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
You might already be planning your Thanksgiving menu as the holiday approaches. Some retailers are offering deals that could help your pockets as you budget for those large family gatherings.
